Radioimmunotherapy (RIT) is a targeted cancer treatment that combines radiation therapy with immunotherapy. It involves the use of monoclonal antibodies that are specifically designed to bind to specific antigens on cancer cells. These antibodies are then linked to a radioactive isotope, which allows for the delivery of targeted radiation directly to the cancer cells.
New to topics? Read the docs here!